Up-to-date information from the January 24.01.-27.01.2022 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the December 13.12.-16.12.2021 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the November 08.11.-11.11.2021 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the October 11-14 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Current information from the meeting on 16-18 August 2021: special issue Ipilimumab

Up-to-date information from the July 19-22 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the July 19-22 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the June 21-24 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.

Up-to-date information from the May 17-20 meeting on new approvals, extensions of indication, newly published EPARs and recently started procedures.